無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管手術用器具および装置の世界市場の予測

GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET FORECAST 2018-2026

発行 Inkwood Research 商品コード 556988
出版日 ページ情報 英文 156 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.73円で換算しております。
Back to Top
心血管手術用器具および装置の世界市場の予測 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET FORECAST 2018-2026
出版日: 2018年09月17日 ページ情報: 英文 156 Pages
概要

当レポートでは、心血管手術用器具および装置の世界市場について調査し、全体的な市場動向、製品・エンドユーザー別および地域別の詳細動向、市場規模の推移と予測、市場の促進要因・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の決定要因

  • 市場促進要因
  • 市場阻害要因
  • 市場機会
  • 課題

第5章 市場区分

  • 製品別の市場 (今後9年間分)
    • 心血管ステント
    • 心臓カテーテル
    • 手術用デバイス
    • イメージング装置
    • インターベンションガイドワイヤ
    • 左心耳 (LAA) 閉鎖装置
    • アテローム除去装置
    • その他
  • エンドユーザー別の市場 (今後9年間分)
    • 日帰り手術センター (ASC)
    • 病院
    • 診療所

第6章 主要指標

  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 主な購入基準
  • 市場機会マトリックス

第7章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、フランス、ドイツ、イタリア、スペインなど)
  • アジア太平洋地域 (インド、中国、日本、韓国、オーストラリアなど)
  • 他の国々 (RoW:中東・アフリカ、ラテンアメリカ)

第8章 企業プロファイル

  • ABBOTT VASCULAR INC.
    • 企業概要
    • 製品ポートフォリオ
    • SCOT分析
    • 戦略展開状況
  • ATRICURE INC
  • ATRIUM MEDICAL CORP
  • BERLIN HEART GMBH
  • BOSTON SCIENTIFIC CORPORATION
  • COOK MEDICAL INC.
  • CORDIS CORP
  • GE HEALTHCARE
  • JOHNSON & JOHNSON
  • MEDTRONIC PLC
  • PHILIPS HEALTHCARE
  • ST. JUDE MEDICAL, INC. (ABBOTT LABORATORIESが買収済)
  • キヤノンメディカルシステムズ
目次
Product Code: 7989

KEY FINDINGS:

Globally, cardiovascular diseases (CVD) are the primary causes of deaths. Hence, the treatment of these diseases is of utmost priority. The global cardiovascular surgical devices market is expected to rise at a CAGR of 8.29% over the forecast period of 2018-2026. The rising incidences of cardiac disorders, growing elderly population, coupled with the advances in technology is primarily responsible for propelling the market ahead.

MARKET INSIGHTS:

The global cardiovascular surgical devices market is segmented on the basis of products and end-users. The products include cardiovascular stents, CRDM, cardiac catheters, surgeries, imaging, interventional guide wires, LAA closure devices, atherectomy devices, etc. The end users for the market are hospitals, ASCs and physician's offices. Rising demand for minimally invasive procedures and favourable reimbursement policies are hugely benefiting the market growth.

REGIONAL INSIGHTS:

The global cardiovascular surgical devices market is geographically spread across North America, Asia-Pacific, Europe and Rest of the World. The Asia-Pacific market is predicted to be the fastest growing market over the forecast period. Advanced robotic surgeries are increasingly being adopted in countries like China, Japan, and South Korea. The North America market is anticipated to hold the highest revenue share by the year 2026 owing to an increase in the number of lifestyle-oriented diseases, technological advancements in cardiology and the rising healthcare expenditure.

COMPETITIVE INSIGHTS:

Johnson & Johnson is a global pioneer in diverse health products. Another company, Abbott Vascular Inc includes a range of coronary interventional products such as coronary dilatation catheters, bleed back control valve, coronary guidewires, and coronary drug-eluting stents. The other major players in the market include Atricure Inc, Atrium Medical Corp, Berlin Heart Gmbh, Boston Scientific Corporation, Cook Medical Inc, Cordis Corp, Ge Healthcare, Medtronic Plc, Philips Healthcare, St. Jude Medical, Inc, and Abbott Vascular Inc.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. AN INCREASE IN THE INCIDENCES OF PERIPHERAL VASCULAR DISEASES (PVDS) AND CVDS
    • 3.2.2. SURGERIES HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS
    • 3.2.3. AMBULATORY SURGERY CENTERS (ASC) ARE WIDELY USED IN TERMS OF END USER

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. INCREASING INCIDENCES OF CARDIAC DISORDERS AND RISE IN OLDER POPULATION
    • 4.1.2. ADVANCES IN TECHNOLOGY
    • 4.1.3. GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
    • 4.1.4. FAVORABLE REIMBURSEMENT POLICIES
  • 4.2. RESTRAINTS
    • 4.2.1. COST OF SURGERIES ARE HIGH
    • 4.2.2. STRICT GOVERNMENT POLICIES
  • 4.3. OPPORTUNITIES
    • 4.3.1. INCREASE IN THE RESEARCH AND DEVELOPMENT
    • 4.3.2. ADVANCEMENTS IN TECHNOLOGIES
    • 4.3.3. APPROVAL OF MEDICAL DEVICES BY THE US FDA
  • 4.4. MARKET CHALLENGES
    • 4.4.1. HIGH COST OF INTERVENTIONAL CARDIOLOGY PROCEDURES
    • 4.4.2. COMPLICATIONS ASSOCIATED WITH THE USAGE OF INTERVENTIONAL CARDIOLOGY DEVICES
    • 4.4.3. STRINGENT REGULATION FOR APPROVAL OF DEVICES
    • 4.4.4. PRICING PRESSURE COUPLED WITH LACK OF PRODUCT DIFFERENTIATION

5. MARKET SEGMENTATION

  • 5.1. MARKET BY PRODUCTS 2018-2026
    • 5.1.1. CARDIOVASCULAR STENTS
      • 5.1.1.1. BIOABSORBABLE STENTS
      • 5.1.1.2. DRUG-ELUTING STENTS
      • 5.1.1.3. BARE METAL STENTS
      • 5.1.1.4. CARDIAC RHYTHM MANAGEMENT DEVICES (CRMD)
    • 5.1.2. CARDIAC CATHETERS
    • 5.1.3. SURGERIES
      • 5.1.3.1. CORONARY SURGERY
      • 5.1.3.2. TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR)
      • 5.1.3.3. HEART VALVE REPAIR/REPLACEMENT
      • 5.1.3.4. HEART TRANSPLANT SURGERY
    • 5.1.4. IMAGING DEVICE
      • 5.1.4.1. IVUS
      • 5.1.4.2. FFR
    • 5.1.5. INTERVENTIONAL GUIDEWIRES
    • 5.1.6. LAA CLOSURE DEVICES
    • 5.1.7. ATHERECTOMY DEVICES
    • 5.1.8. OTHER PRODUCTS
  • 5.2. MARKET BY END USER 2018-2026
    • 5.2.1. ASCS
    • 5.2.2. HOSPITALS
    • 5.2.3. PHYSICIAN'S OFFICE

6. KEY ANALYTICAL

  • 6.1. PORTER'S FIVE FORCES ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTES
    • 6.1.3. BARGAINING POWER OF BUYERS
    • 6.1.4. BARGAINING POWER OF SUPPLIERS
    • 6.1.5. THREAT OF RIVALRY
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. KEY BUYING CRITERIA
  • 6.4. OPPORTUNITY MATRIX

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES (U.S.)
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM (UK)
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. ITALY
    • 7.2.5. SPAIN
    • 7.2.6. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. INDIA
    • 7.3.2. CHINA
    • 7.3.3. JAPAN
    • 7.3.4. SOUTH KOREA
    • 7.3.5. AUSTRALIA
    • 7.3.6. REST OF APAC
  • 7.4. REST OF THE WORLD
    • 7.4.1. MIDDLE EAST AND AFRICA
    • 7.4.2. LATIN AMERICA

8. COMPANY PROFILES

  • 8.1. ABBOTT VASCULAR INC.
    • 8.1.1. COMPANY OVERVIEW
    • 8.1.2. PRODUCT PORTFOLIO
    • 8.1.3. SCOT ANALYSIS
    • 8.1.4. STRATEGIC INITIATIVES
  • 8.2. ATRICURE INC
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. SWOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. ATRIUM MEDICAL CORP
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. SWOT ANALYSIS
  • 8.4. BERLIN HEART GMBH
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. SWOT ANALYSIS
  • 8.5. BOSTON SCIENTIFIC CORPORATION
    • 8.5.1. COMPANY OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. SWOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. COOK MEDICAL INC.
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCT PORTFOLIO
    • 8.6.3. SWOT ANALYSIS
    • 8.6.4. STRATEGIC INITIATIVES
  • 8.7. CORDIS CORP
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
  • 8.8. GE HEALTHCARE
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. SWOT ANALYSIS
    • 8.8.4. STRATEGIC INITIATIVES
  • 8.9. JOHNSON & JOHNSON
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCT PORTFOLIO
    • 8.9.3. SWOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVES
  • 8.10. MEDTRONIC PLC
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. SWOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVES
  • 8.11. PHILIPS HEALTHCARE
    • 8.11.1. COMPANY OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. SWOT ANALYSIS
    • 8.11.4. STRATEGIC INITIATIVES
  • 8.12. ST. JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)
    • 8.12.1. COMPANY OVERVIEW
    • 8.12.2. PRODUCT PORTFOLIO
    • 8.12.3. SWOT ANALYSIS
    • 8.12.4. STRATEGIC INITIATIVES
  • 8.13. CANON MEDICAL SYSTEMS CORPORATION
    • 8.13.1. COMPANY OVERVIEW
    • 8.13.2. PRODUCT PORTFOLIO
    • 8.13.3. SWOT ANALYSIS
    • 8.13.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 2 TYPE OF SURGERY AND PRICE IN THE US
  • TABLE 3 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET BY PRODUCTS 2018-2026 ($ MILLION)
  • TABLE 4 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN CARDIOVASCULAR STENTS BY GEOGRAPHY2018-2026 ($MILLION)
  • TABLE 5 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN CARDIOVASCULAR STENTS BY TYPES 2018-2026 ($MILLION)
  • TABLE 6 GLOBAL CARDIOVASCULAR STENTS MARKET IN BIOABSORBABLE STENTS BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 7 GLOBAL CARDIOVASCULAR STENTS MARKET IN DRUG-ELUTING STENTS MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 8 GLOBAL CARDIOVASCULAR STENTS MARKET IN BARE METAL STENTS BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 9 GLOBAL CARDIOVASCULAR STENTS MARKET IN CRMD BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 10 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN CARDIAC CATHETERS BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 11 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN SURGERIES BY GEOGRAPHY 2018-2026($ MILLION)
  • TABLE 12 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN SURGERIES BY TYPES 2018-2026($ MILLION)
  • TABLE 13 GLOBAL SURGERIES MARKET IN CORONARY SURGERY BY GEOGRAPHY2018-2026($ MILLION)
  • TABLE 14 GLOBAL SURGERIES MARKET IN TMR SURGERY BY GEOGRAPHY2018-2026($ MILLION)
  • TABLE 15 GLOBAL SURGERIES MARKET IN HEART VALVE REPLACEMENT BY GEOGRAPHY 2018-2026($MILLION)
  • TABLE 16 GLOBAL SURGERIES MARKET IN HEART TRANSPLANT SURGERY BY GEOGRAPHY 2018-2026($MILLION)
  • TABLE 17 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN IMAGING DEVICE BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 18 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN IMAGING DEVICE BY TYPE 2018-2026 ($MILLION)
  • TABLE 19 GLOBAL IMAGING DEVICE MARKET IN IVUS MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 20 GLOBAL IMAGING DEVICE MARKET IN FFR MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 21 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN INTERVENTIONAL GUIDE WIRES BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 22 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN LAA CLOSURE DEVICES BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 23 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN ATHERECTOMY DEVICES BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 24 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET IN OTHER PRODUCTS MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
  • TABLE 25 GLOBAL CARDIOVASCULAR SURGERY DEVICE MARKET BY END USER 2018-2026 ($MILLION)
  • TABLE 26 GLOBAL CARDIOVASCULAR SURGERY DEVICE MARKET IN ASCS MARKET BY GEOGRAPHY 2018-2026($MILLION)
  • TABLE 27 COMPARISON OF REIMBURSEMENT FOR ASCS, HOSPITAL OUTPATIENT DEPARTMENTS, AND PHYSICIANS' OFFICES IN THE US
  • TABLE 28 GLOBAL CARDIOVASCULAR SURGERY DEVICE MARKET IN HOSPITAL BY GEOGRAPHY 2018-2026($MILLION)
  • TABLE 29 GLOBAL CARDIOVASCULAR SURGERY DEVICE MARKET IN PHYSICIANS OFFICES BY GEOGRAPHY 2018-2026($MILLION)
  • TABLE 30 GLOBAL CARDIOVASCULAR SURGICAL DEVICE MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 31 NORTH AMERICA CARDIOVASCULAR SURGICAL DEVICE MARKET, BY COUNTRIES 2018-2026($ MILLION)
  • TABLE 32 EUROPE CARDIOVASCULAR SURGICAL DEVICE MARKET BY COUNTRIES 2018-2026($ MILLION)
  • TABLE 33 NUMBER OF CARDIOLOGISTS IN SPAIN
  • TABLE 34 ASIA PACIFIC CARDIOVASCULAR SURGICAL DEVICE MARKET BY COUNTRIES 2018-2026($ MILLION)
  • TABLE 35 REST OF WORLD CARDIOVASCULAR SURGICAL DEVICE MARKET BY COUNTRIES 2018-2026($ MILLION)

FIGURES LIST

  • FIGURE 1 GLOBAL CARDIOVASCULAR SURGERY DEVICE MARKET IN ASCS 2018-2026 ($MILLION)
  • FIGURE 2 GLOBAL CARDIOVASCULAR SURGERY DEVICE MARKET IN HOSPITAL MARKET 2018-2026 ($MILLION)
  • FIGURE 3 GLOBAL CARDIOVASCULAR SURGERY DEVICE MARKET IN PHYSICIANS OFFICES 2018-2026 ($MILLION)
  • FIGURE 4 UNITED STATES CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026 ($MILLION)
  • FIGURE 5 CANADA CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026 ($MILLION)
  • FIGURE 6 THE UNITED KINGDOM CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026 ($ MILLION)
  • FIGURE 7 FRANCE CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 8 GERMANY CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 9 ITALY CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 10 SPAIN CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 11 REST OF EUROPE CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 12 INDIA CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 13 CHINA CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 14 JAPAN CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 15 SOUTH KOREA CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 16 AUSTRALIA CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 17 REST OF APAC CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 18 MIDDLE EAST AND AFRICA CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
  • FIGURE 19 LATIN AMERICA CARDIOVASCULAR SURGICAL DEVICE MARKET 2018-2026($ MILLION)
Back to Top